Tenax Therapeutics (TENX) Financials

$1.85

$0.05 (2.78%)

As on 02-Sep-2026 16:21EDT

Market cap

$80 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	0.01	0.11	0.11
Gross Profit	--	--	--	-0.01	-0.11	-0.11
Operating Expenses	68.61	56.39	19.49	8.23	11.05	32.73
Operating Profit (EBIT)	-68.61	-56.39	-19.49	-8.23	-11.05	-32.73
Other Income	--	--	--	--	--	--
Profit before Tax	-64.86	-52.60	-17.60	-7.71	-11.05	-32.47
Provision for Tax	--	--	--	0.00	0.00	0.26
Profit after Tax (Net Income)	-64.86	-52.60	-17.60	-7.71	-11.05	-32.47
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-32.47

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	113.59	97.07	91.99	8.10	1.49	4.24
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	0.06	0.18
Current Liabilities	8.07	7.16	4.69	3.59	1.85	1.56
Total Liabilities	129.74	104.23	96.69	11.68	3.40	5.99

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	--	0.00	0.20	0.30
Current Assets	121.66	104.23	96.69	11.68	3.21	5.69
Total Assets	129.74	104.23	96.69	11.68	3.40	5.99
Total Debt*	--	--	--	0.50	0.81	0.29
Net Current Assets	113.59	97.07	91.99	8.10	1.36	4.13

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-35.80	-14.81	-5.90	-12.01	-10.86
Cash Flow from Investing Activities	--	--	--	0.00	0.00	0.45
Cash from Financing Activities	--	38.51	99.87	13.57	8.55	9.74
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.49	-1.34	-1.15	-31.04	-669.57	-2,055.34
Cash EPS ($)	--	-1.34	-1.15	-30.91	-662.70	-2,048.44
Adjusted Book Value ($)	--	2.48	6.02	32.60	90.47	268.65
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.91	-0.97	-23.77	-728.05	-687.10
Free Cash Flow per Share ($)	--	-0.91	-0.97	-23.77	-728.19	-687.43

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-55.64	-35.00	-141.49	-323.22	-686.12
ROE (%)	-61.58	-55.64	-35.17	-160.80	-385.12	-732.21
ROA (%)	-54.48	-52.36	-32.48	-102.20	-235.14	-505.01
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	-129.28	30.39	65.99	-229.69
Net Profit Growth (%)	-106.03	-198.82	-128.27	30.20	65.98	-229.64
EPS Growth (%)	-29.00	-0.16	0.96	0.95	0.67	-0.94
Book Value Growth (%)	-14.48	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-9.09	-5.37	-0.01	0.00	0.00
Price / Book Value	0.72	4.92	1.03	0.01	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.14	-7.23	0.02	1.20	0.12	0.16
Close Price ($)	14.55	12.19	6.19	22.00	178.24	1,664.00
High Price ($)	18.29	14.22	1,830.40	344.00	2,335.04	5,888.00
Low Price ($)	5.66	4.63	2.77	12.08	128.00	1,616.00
Market Cap ($ Cr)	79.71	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	0.06	0.54	0.07
Short term debt to equity ratio	--	--	--	0.06	0.50	0.03
Current Ratio	15.07	14.56	20.60	3.26	1.74	3.64
Quick Ratio	15.07	--	--	--	--	--
Interest Coverage	--	--	-766.30	-320.73	-2,485.58	-34,218.56

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	60,832.56	2,107.83	2,710.49
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.